Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 101 related to Aronoff: Glucose metabolism and regulation: beyond insulin and glucagon. (0.10 sec) 

Glucose metabolism and regulation: beyond insulin and glucagon


SL Aronoff, K Berkowitz, B Shreiner, L Want - Diabetes Spectrum, 2004 - Am Diabetes Assoc
Insulin and glucagon are potent regulators of glucose metabolism. For decades,
we have viewed diabetes from a bi-hormonal perspective of glucose regulation.
This perspective is incomplete and inadequate in explaining some of the ...
Cited by 35 - Related articles - BL Direct - All 2 versions

New insights into glucose regulation


DF Kruger, CL Martin, CE Sadler - The Diabetes Educator, 2006 - tde.sagepub.com
This review article describes the regulation of glucose homeostasis in subjects
with and without diabetes based on the emergence of new information and
discusses modes of action, attributes, and limitations of current diabetes ...
Cited by 10 - Related articles - All 3 versions

Effects of exenatide versus sitagliptin on postprandial glucose, insulin and glucagon …


RA DeFronzo, T Okerson, P Viswanathan, X … - Current Medical Research and Opinion®, 2008 - informahealthcare.com
Methods: This double-blind, randomized cross-over, multi-center study was
conducted in metformin-treated T2D patients: 54% female; BMI: 33 ± 5 kg/m 2 ;
HbA 1c : 8.5 ± 1.2%; 2-h PPG: 245 ± 65 mg/dL. Patients received exenatide ...
Cited by 26 - Related articles - All 6 versions

Efficacy and tolerability of exenatide monotherapy over 24 weeks in antidiabetic drug— …


TJ Moretto, DR Milton, TD Ridge, LA … - Clinical Therapeutics, 2008 - Elsevier
Methods: This 24-week, double-blind, placebo-controlled, parallel-group study
was conducted at 23 centers across the United States, Puerto Rico, Romania,
Russia, and India. Patients aged ≥18 years with type 2 diabetes were ...
Cited by 16 - Related articles - All 2 versions

[CITATION] Improvements in cardiovascular risk factors accompanied improved glycemic control and weight …


DM Kendall, L Blonde, SM Mac, G Xue-Song, … - Program and abstracts of the American Diabetes …
Cited by 6 - Related articles

Overview of glucagon-like peptide-1 analogs and dipeptidyl peptidase-4 inhibitors for type 2 …


RE Pratley - The Medscape Journal of Medicine, 2008 - pubmedcentral.nih.gov
Two classes of therapies target the incretin system. The first, glucagon-like
peptide-1 (GLP-1) agonists (exemplified by exenatide and liraglutide), have
demonstrated considerable efficacy in clinical trials, reducing hemoglobin ...
Cited by 8 - Related articles - All 7 versions

[CITATION] Liraglutide: superior glycemic control vs exenatide when added to metformin and/or SU in …


L Blonde, J Rosenstock, G Sesti, WE Schmidt, … - Canadian Diabetes Association/Canadian Society of …, 2008
Cited by 17 - Related articles

Glucagon-like peptide 1 (GLP-1) in the treatment of diabetes


MA Nauck - Hormone and Metabolic Research, 2004 - thieme-connect.com
Glucagon-like peptide 1 (GLP-1) was discovered as an incretin (insulinotropic
gut) hormone. Biological actions of GLP-1 in healthy and type 2 diabetic
subjects include (a) stimulation of insulin secretion in a ...
Cited by 38 - Related articles - All 5 versions

[CITATION] Tools and techniques for fighting the obesity epidemic


RA Thomas, CK Dlugosz - Program and abstracts of the American Pharmacists …, 2006
Cited by 2 - Related articles

[CITATION] Adjunctive therapy with amylin analogue pramlintide leads to a combined improvement in …


RE Ratner, LL Want, MS Fineman, MS Velte, … - Diabet Med, 2004
Cited by 2 - Related articles


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google